KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer

Dingheng Lu(Union Hospital), Yifei Xing(Union Hospital)
Cell Death and Disease
August 12, 2021
Cited by 49


Related Papers